Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center
| dc.contributor.author | Uzay, Ant | |
| dc.contributor.author | Gundogdu, Yasemin | |
| dc.contributor.author | Kosan, Baris | |
| dc.contributor.author | Yetis, Tugba | |
| dc.contributor.author | Karti, S. Sami | |
| dc.date.accessioned | 2025-10-16T15:13:26Z | |
| dc.date.issued | 2024 | |
| dc.identifier.doi | 10.1002/cam4.7292 | |
| dc.identifier.other | WOS:001224179500001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/5820 | |
| dc.publisher | WILEY | |
| dc.source | CANCER MEDICINE | |
| dc.subject | busulfan | |
| dc.subject | graft versus host disease | |
| dc.subject | stem cell transplantation | |
| dc.subject | toxicity | |
| dc.subject | treosulfan | |
| dc.title | Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center | |
| dc.type | Article |
